Wei Guo

Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

Steven O’Day, Alexander M.M. Eggermont, Vanna Chiarion‐Sileni et al. · Journal of Clinical Oncology · 2013 · 386 citations · Full text

Medicine, Oncology, Pharmacology +17

A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer

Mark A. Socinski, Jonathan W. Goldman, Iman El‐Hariry et al. · Clinical Cancer Research · 2013 · 214 citations

Medicine, Oncology, Pharmacology +14

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies

Jonathan W. Goldman, Robert N. Raju, Gregory Gordon et al. · BMC Cancer · 2013 · 116 citations · Full text

Medicine, Oncology, Pharmacology +15

Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells

Xinwei Liu, Lihui Wang, Wei Cui et al. · Oncotarget · 2016 · 114 citations · Full text

Medicine, Oncology, Pharmacology +17

TNF-α augments CXCL10/CXCR3 axis activity to induce Epithelial-Mesenchymal Transition in colon cancer cell

Zhengcheng Wang, Xiang Ao, Zhilin Shen et al. · International Journal of Biological Sciences · 2021 · 94 citations · Full text

Medicine, Cell Biology, Oncology +17